Floatz logo

Deupirfenidone

Drug Interactions

PureTechSmall moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Drug Interactions cohort.

Asset / SponsorPhaseRating
ETONOGESTREL
University of Sao Paulo
Phase 4BB
Rosuvastatin
Bayer
Phase 1CC

Same molecule, other indications

Deupirfenidone is also rated in:

idiopathic pulmonary fibrosisDormant
B
Indicative ·
59 / 100
View asset →
lymphedemaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →